Review
Open access
Oct 2026
CAR T-Cell Therapy in Hematological Malignancies: Mechanisms, Innovations, and Challenges
Simple Summary Chimeric antigen receptor (CAR) T-cell therapy is a revolutionary immunotherapy that engineers a patient’s own immune T cells to specifically target and destroy malignant cells in hematological malignancies. This approach has transformed the treatment of relapsed acute lymphoblastic leukemia, lymphomas,...
Alaa A. A. Aljabali, Mohammad A. Obeid, A. Alqudah et al.
· Cancers · 0 citations